India-UK FTA Leaked Draft Reveals Nobody’s Gain Except Big Pharma
[Shirin Syed] The draft of the UK-India Free Trade Agreement (FTA) chapter on intellectual property, leaked on October 31, reveals that there are several TRIPS-plus provisions which will devastate the global supply of generic medicines. The FTA contains harmful IP provision such as diluting the patentability standards, overriding section 3(d) of the Indian Patents Act and eliminating pre-grant opposition. If implemented, these provisions would pose a serious threat to the accessibility and affordability of medicines in India and globally.
Read More


